Skip to main content

Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021

Abstract

Introduction

The worldwide prevalence of Diabetic Retinopathy was recently estimated to be 34.6%. The prevalence of diabetic retinopathy in developed nations has been thoroughly investigated, and risk factors are well understood. However, there is a shortage of information in the study areas about the prevalence and contributing factors of diabetic retinopathy among type two diabetes patients.

Objective

The aim of this study was to assess the prevalence of diabetic retinopathy and associated factor among type 2 diabetic patients who were on follow up services at northwest Amhara comprehensive specialized hospitals diabetic care units.

Method

An institutional based cross-sectional study was conducted at northwest Amhara comprehensive specialized hospitals from October 15 to November 15, 2021, among 496 diabetes patients. Systematic random sampling technique was used. Data were collected by utilizing a semi-structured questionnaire and a direct Topcon retinal camera inspection. Then data were coded, entered, and exported to SPSS version 23 from EPI-Data version 4.6. All variables with P-value < 0.25 in the binary logistic regression analyses were included in the multivariable regression analysis. The degree of association was interpreted by using the adjusted odds ratio with 95% confidence intervals, and the significance level was declared at P-value < 0.05. The Hosmer–Lemeshow test was used to check the fitness of the model.

Result

The prevalence of diabetic retinopathy among type two diabetes patients was 36.3%. Sex [AOR = 3.25, 95% CI (1.80, 6.68)], visiting health institution [AOR = 0.027, 95% CI (0.003, 0.253)], educational level [AOR = 4.23, 95% CI (1.09, 16.47)], glycemic control [AOR = 0.099, 95% CI (0.02, 0.49)], hypertension status (AOR = 2.56, 95% CI (1.01, 6.45)] were significantly associated with diabetic retinopathy.

Conclusion

In this study less than half of diabetic patients had diabetic retinopathy. Sex, visiting health institution, educational level, glycemic control, and hypertension status were significantly associated with diabetic retinopathy.

Peer Review reports

Background

Diabetes mellitus is a chronic disease of elevated blood glucose levels due to either suboptimal production of insulin by the pancreas or peripheral resistance of the body to insulin [1]. The main causes for DM are defects in insulin secretion, insulin action, or both [2]. It is the leading cause of end-stage renal disease (ESRD), traumatic lower extremity amputations, cardiovascular diseases, and adult blindness [3].

Globally the prevalence of diabetes mellitus in 2014 was 8.5% among the adult population [4]. The prevalence of diabetes has been steadily increasing for the past three decades and is growing most rapidly in low and middle-income countries [5]. Diabetic retinopathy is a known complication of diabetes mellitus and it is characterized by varying degrees of microaneurysm, haemorrhage, hard exudates, cotton-wool spots, venous changes, and new vessel formation involved in the peripheral retina, macula, or both [6]. Globally, the prevalence of diabetic retinopathy among diabetic patients is estimated to be 27.0%, which leads to 0.4 million blindness in the world [7]. Based on a pooled analysis of various hospital-based studies the prevalence of diabetic retinopathy is reported to be 31.6% in Africa [8] and 19.48%in Ethiopia [9]. The International Diabetic Federation estimated that the global prevalence of diabetic retinopathy in 2019 was more than 25% [10].

Globally, visual impairment has decreased, but the number of people who are blind as a result of diabetic retinopathy grew from 0.2 million to 0.4 million [11]. One of the leading global causes of irreversible blindness and the main cause of blindness in adults of working age is diabetic retinopathy. Approximately 80% of people with type 2 diabetes are thought to develop retinopathy [12, 13].

In Ethiopia, the prevalence of diabetic retinopathy at study conducted in Jima, Arbaminch and Debremarkos hospitals was 41.4%, 13%, and 18.5% respectively [5, 14, 15].

In recent years, certain measures have been taken to control diabetic retinopathy. WHO launched the Global Diabetes Compact, a global initiative aiming for sustained improvements in diabetic retinopathy prevention and care, with a particular focus on supporting low- and middle-income countries [16]. Even though, the prevalence of diabetic retinopathy and its associated factors in developed nations has been thoroughly investigated, there is a shortage of information in the study areas about the prevalence and contributing factors of diabetic retinopathy among type two diabetes patients. Therefore, there is a need for more information on the prevalence of diabetic retinopathy in addition to its associated factors in Ethiopia.

Objective

To assess the prevalence of diabetic retinopathy and associated factors among type 2 diabetic patients attending at Northwest Amhara comprehensive specialized Hospitals, Northwest Ethiopia, 2021.

Methods

Study design and period

An institutional-based cross-sectional study was implemented from October 15 to November 15, 2021.

Study area

The study was conducted from October 15 to November 15, 2021, at Comprehensive Specialized Hospitals in the Northwest Amhara regional state. According to the Amhara National Regional Health Bureau’s Annual Performance Report, the region has 81 hospitals, 858 health centres, and 3560 health posts [17]. Among those 81 hospitals in the region, there are a total of four comprehensive specialized Hospitals in the Northwest Amhara Region such as; Debre Markos, Felege Hiwot, Tibebe Gion, and University of Gondar hospital are found in the Northwest of Amhara. Each comprehensive specialized Hospital serves 3.5–5 million people.

Source and study population

Source population

The source population was all diabetes patients who attend Northwest Amhara comprehensive specialized Hospitals, diabetic clinic.

Study population

The study population was all adult diabetes patients who attend Northwest Amhara comprehensive specialized Hospitals, diabetic clinic during the data collection period.

Inclusion and exclusion criteria

Inclusion criteria

Adult diabetes patients who were on diabetic follow up during the study period were included in the study.

Exclusion criteria

All diabetes patients with incomplete medical chart recorded were excluded from the study.

Sample size and sampling procedure

Sample size (N) was calculated using single population proportion formula. Considering the following assumption: standard normal distribution with confidence interval (CI) of 95% (Z = 1.95), tolerable margin of error (d = 0.04), and anticipated proportion of diabetic retinopathy 14.8% (p) taken from a study conducted in Arbaminch

$$\begin{array}{c}\mathrm n=\;{({\mathrm Z}_{{\mathrm\alpha/2}_{}})}^2\;\mathrm p\;(1-\mathrm p)/\mathrm d^2\\\mathrm n=\;{(1.96)}^2.\;0.148(1-0.148)/\;{(0.04)}^2\\\mathrm n=\;303\end{array}$$

By considering 1.5 design effects the final sample size was calculated as:

$$\mathrm{Design}\;\mathrm{effect}\;=\;303\;\times\;1.5=\;455$$

Adding 10% none response rate and the final sample size were 500.

  • Where n = minimum sample size required to the study

  • d = margin of error

  • p = prevalence of diabetic retinopathy

  • Zα/2 = value of standard normal distribution

Sampling procedure

To select study subject systematic random sampling was used from those who full fill the inclusion criteria. The patient’s follow-up register in the Diabetic Clinic was used as a sampling frame.

Variables

Dependent variable

  • ✓ diabetic retinopathy

Independent variable

  • ➢ Sociodemographic variables:

    • ✓ Age of the patient Sex (male, female) Education level (no education, primary, secondary, diploma and above), Place of Residency (urban, rural) Income of the patient, Occupation

  • ➢ Clinical factors

    • ✓ Hypertension, Blood glucose HbA1C, Chronic kidney disease, BMI, Duration of illness, Treatment modality

  • ➢ Diabetic care

    • ✓ Number of visit, Attending health education

Operational definition

Diabetic retinopathy: on retinal camera examination the presence of micro aneurysms, hemorrhages, exudation, cotton wool spot, and/or new vessels [18]

Background diabetic retinopathy: on retinal camera examination the presence of micro aneurysms, hemorrhages, exudation, and/or cotton wool spot [18]

Maculopathy: on retinal camera examination the presence of exudates within 1 disc diameter (DD) of the fovea, circinate/tracking within 2DD of the fovea [19]

Pre-proliferative DR:—on retinal camera examination the presence of 5 or more cotton wool spots, large blot hemorrhages, intra-retinal micro vascular abnormalities (IRMAs), and/or venous abnormalities [32].

Proliferative DR:—on retinal camera examination the presence of new vessel elsewhere, new vessel on disc and/or pre-retinal/vitreous hemorrhage [19]

Data collection instruments and procedures

Data was collected using semi-structured questionnaire chart review and direct Topcon retinal camera examination. The questionnaire was adapted from different literature with modification. The investigators have developed the questionnaire for face to face interviews with diabetic patients. The questionnaire has four-part, part 1 socio-demographic variable, part 2 diabetic cares, part 3 treatment modality, and part 4 clinical factors. Data were collected by 4 optometric nurses (one optometric nurse for one hospital) and one supervisor who are trained about diabetic retinopathy screening and who are working in each study area during the study period. Those patients who attend diabetic clinic and fulfill the inclusion criteria have undergo Topcon retinal camera examination following pupil dilation. The laboratory investigation like, fasting blood glucose, glaciated hemoglobin value were collected from the patient’s document.

Data processing and analysis

After data collection, the collected data were cleaned and checked for completeness. Data were entered by using Epi data version 4.6, after being coded and analyzed using SPSS version 23. Descriptive statistics was used in the analysis of medians, frequencies, and percentages for all variables. Data were presented in tables and charts. The association between dependent and independent variables was assessed by using a binary logistic regression analysis model. Adjusted odds ratio (AOR) was used to estimate the strength of association. All variables associated with diabetic retinopathy with a p-value less than 0.25 in the bivariable analysis, was further analyzed using multivariable analyses to control potential confounding factors. Variables with a p-value less than 0.05 were declared to be associated with Diabetic retinopathy.

Data quality control

A pre-test was done on 5% of the total sample size to make sure whether the questionnaire is appropriate and to ensure its validity in the study population before the actual data collection period. After pretest, training was given to all data collectors and supervisors on the purpose of the study, how to get informed consent and the technique of selecting the study participants from each diabetic clinics. Supervision was conducted by the supervisors and principal investigators. All questionnaires were translated into local languages (Amharic) before data collection. Consistency was checked by a back-translation by a language expert both in English and in local languages. At the end of each data collection day, the supervisors were checked for completeness or fulfillment of the questionnaires and the quality of the recorded information.

Result

Socio-demographic characteristics

A total of 496 participants were included in this study with a response rate of 99%. Diabetic retinopathy was observed among 180 diabetic patients. With regard to gender distribution more than half (58.1%) of were male. Considering to educational status more than one-third were (36.7%) of them were having college and above education level. Around 188(37.9%) of study populations were employs meaning they have paying job either from governmental or nongovernmental organizations. Regarding monthly income half of the respondents have 1000–3000 birr with median 2000 & IQR ± 2000 birr (Table 1).

Table 1 Socio-demographic characteristics of patients attending at diabetic clinics at Northwest Amhara comprehensive specialized Hospitals, 2021 (n = 496)

Clinical factors, treatment modality and diabetic care of the patient

In this study the number of hypertensive patients was 168(33.9%). More than half, 347(70%) of the patients whose glycemic level were less than 7 and the other 149(30%) were patient whose glycemic level were greater than 7. About one third, 131(26.4%) of the patient had a body mass index (BMI) of 18.5–24.9 kg/m2. Among those 496 patients in the study 95(19.2%) of them used insulin and 237(47.8%) of them used oral antiglycemic and the remaining 164(33%) used both insulin and oral antiglycemic agents. About 248(50.1%) of the patients visit health institution for their diabetic case every six month. Nearly half, 209(42.1%) of the patient attend the education about diabetic which is given in the hospital (Table 2).

Table 2 Clinical, treatment modality and diabetic care factors among type 2 diabetic patients attending at diabetic clinic at Northwest Amhara comprehensive specialized Hospitals, 2021(n = 496)

Prevalence of diabetic retinopathy among type 2 DM patients

The result of this study showed that 36.3% with 95% CI (29.8, 47.6) of study participants had had diabetic retinopathy and the remaining 313(63.7%) did not have diabetic retinopathy. Therefore, as shown in Fig. 1 below the prevalence of retinopathy among type 2 diabetic patient was 36.3%

Fig. 1
figure 1

Prevalence of diabetic retinopathy and associated factors among type 2 diabetic patients attending at Northwest Amhara comprehensive specialized Hospitals, Northwest Ethiopia, 2021

Associated factors of diabetic related retinopathy

Sex, visiting health institutions every month for diabetic care, an educational level which is a diploma and above, glycemic control less than 7, and having hypertension were found to have a significant association with diabetic retinopathy among type two diabetic patients.

For males, the odds of diabetic retinopathy were 3.25 times that of females [AOR = 3.25, 95% CI (1.80, 6.69)]. Patients who visit health institutions for their diabetic case every month had about 97% [AOR = 0.027, 95% CI (0.003, 0.253)] less chance of diabetic retinopathy than those patients who visit health institutions for their diabetic case every six months. The odds of no education were 4.23 times compared to a diploma and above [AOR = 4.23 95% CI (1.09, 16.47)]. It was also observed that patients with glycemic control less than 7 had about 9.9% less chance [AOR = 0.099, 95% CI(0.02, 0.49)] to diabetic retinopathy compared with patients with glycemic control greater than 7. Hypertensive patients had about 2.56 times the chance of diabetic retinopathy than non-hypertensive patients [AOR = 2.56, 95% CI (1.01, 6.45)]. The other covariates age, residence, occupation and BMI does not have a significant effect on Diabetic retinopathy (Table 3).

Table 3 Factors associated with diabetic retinopathy among type two diabetic patients attending diabetic clinic at Northwest Amhara comprehensive specialized Hospitals, 2021(n = 496)

Discussion

Diabetic retinopathy (DR) is a well-known micro vascular complication of diabetes mellitus (DM) and it is one of major global health concern, which places a huge burden on the health care system [8].

The result of this study showed that 36.3% with 95% CI (29.8, 47.6) of study participants had diabetic retinopathy. This finding is in line with a study conducted in Armenia 36.2% [20]. Even though there is a difference in socioeconomic status and level of health sector development, the possible reason for the similarity between the current study and the study in Armenia might be using a similar study population (diabetic patients), study unit and study design.

This finding is higher than a study conducted in Arbaminch which is 13% [21], and in China 8.1% [22]. However, this finding is lower than a study conducted in Jimma university Hospital 41.4% [23], Kenya 41% [24], and Babol teaching hospitals, Iran 64.1% [25]. The possible reason for this difference might be due to differences in methodology, sample size, time variation in the study period and different health-seeking behaviour among the study participant.

In the binary logistic regression model, five variables are found to be predictive factors for diabetic retinopathy. These variables are sex, number of visits, glycemic control, educational level, and hypertension status.

The odds of diabetic retinopathy for male were 3.25 times that of females [AOR = 3.25, 95% CI (1.80, 6.69)]. This study was consistent with the study conducted in Pakistan and wales [26, 27]. But a study conducted in Embu Provincial General Hospital, Central Kenya revealed that there was no discernible sex difference in the prevalence of any diabetic retinopathy [28]. The possible explanation might be Neuroretinal function is more abnormal in males than in females for adults with type 2 diabetes. These results suggest that, relative to males, females may have some protection from, or resistance to, neurodegenerative changes that precede the development of background retinopathy in type 2 diabetes [29].

The odds of diabetic retinopathy for diabetic patients who visit health institutions for their diabetic case every month had about 2.7% [AOR = 0.025, 95% CI (0.003, 0.253)] less chance diabetic retinopathy than those patients who visit health institutions for their diabetic case every six months. A similar finding was reported in a study conducted in Ghana [30].This may be due to, most diabetic patients in this study being appointed every 6 months and more. This contributes to poor glycemic control. Moreover, visits to the clinic were limited to the prescription of medications.

The odds of diabetic retinopathy among diabetic patients who had no education was 4.23 times [AOR = 4.23 95% CI (1.09, 16.47)] compared to diabetic patients who had a diploma and above. This study was consistent with the study conducted in Japan [31]. The possible explanation might be Individuals with lower educational levels have limited income, poor occupational opportunities, and reduced access to healthcare services and information. Therefore patients with the lowest socioeconomic status and household income have been shown to have the highest prevalence of retinopathy [32].

The odds of diabetic retinopathy among diabetic patients with glycemic control (HbA1c less than 7) had 9.9% [AOR = 0.099, 95% CI (0.02, 0.49)] less risky for diabetic retinopathy when compared to patients with glycemic control (HbA1c greater than 7). This finding is in line with a study done in Tanzania and Australia [33, 34]. The possible explanation might be individuals with poor glycemic control had a chance of nearly 4 times the risk for diabetic retinopathy. Glycemic control remains an important factor in the presence and progression of diabetic retinopathy. HbA1c seems to be an indicator which can demonstrate exactly the degree of glycemic control, while sudden variations of blood glucose may play an important role in diabetic retinopathy; therefore, glycemic control may be useful to predict DM complications, such as diabetic retinopathy.

The odds of diabetic retinopathy among diabetic patients with hypertension had about 2.56 times [AOR = 2.56, 95% CI (1.01, 6.45)] chance of diabetic retinopathy than non-hypertensive patients. This finding is similar to the study conducted in Khartoum, Sudan and Arbaminch, Ethiopia [5, 35]. A possible explanation might be Diabetic retinopathy prevalence is related to blood pressure levels [36]. It has been observed that the prevalence of hypertension is higher in diabetic subjects than in the general population and it also plays a major role in the progression of diabetic retinopathy. The possible mechanisms by which hypertension affects diabetic retinopathy are hemodynamic (impaired autoregulation and hypoperfusion) and secondly through Vascular Endothelial Growth Factor, as it has been observed that hypertension independent of hyperglycemia up-regulates the Vascular Endothelial Growth Factor expression in retinal endothelial cells and ocular fluids [37].

Strength and limitations

This study is the first to apply multicenter approach in the Northwest Amhara region to assess prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients. However, the study adopted a cross-sectional study design and comprised a relatively smaller number of participants.

Conclusion

This study revealed that the prevalence of diabetic retinopathy was high (36.3%). Sex, number of visits, educational level, glycemic control and hypertension were found to have significantly associated with diabetic retinopathy.

This study result will help as a guideline for decision-makers and program planners at the time to design and implement of intervention. Moreover, the result of this study could be used as a literature for future researchers and be a clue for further studies to be done on the prevalence of retinopathy among diabetes type 2 patients.

Availability of data and materials

Data will be available upon request from the corresponding author.

Abbreviations

AOR:

Adjusted odds ratio

BMI:

Body mass index

CKD:

Chronic kidney disease

COR:

Crude odds ratio

DD:

Disc diameter

DM:

Diabetes mellitus

DR:

Diabetic retinopathy

ESRD:

End stage renal disease

ETDRS:

Early treatment diabetic retinopathy study

IQR:

Inter quartile range

NPDR:

Non-proliferative diabetic retinopathy

OR:

Odds ratio

USA:

United States of America

References

  1. Dereje N, Earsido A, Temam L, Abebe A. Prevalence and associated factors of diabetes mellitus in Hosanna Town, Southern Ethiopia. Ann Glob Health. 2020;86(1):18.

    Article  Google Scholar 

  2. Surrena H. Handbook for Brunner and Suddarth's textbook of medical-surgical nursing: Lippincott Williams & Wilkins; 2010.

  3. Gilhotra RA, Rodrigues BT, Vangaveti VN, Kan G, Porter D, Sangla KS, et al. Non-traumatic lower limb amputation in patients with end-stage renal failure on dialysis: an Australian perspective. Ren Fail. 2016;38(7):1036–43.

    Article  CAS  Google Scholar 

  4. Organization WH. Global diffusion of eHealth: making universal health coverage achievable: report of the third global survey on eHealth: World Health Organization; 2017.

  5. Chisha Y, Terefe W, Assefa H, Lakew S. Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study. PLoS One. 2017;12(3):e0171987.

    Article  Google Scholar 

  6. Group ETDRSR. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology. 1991;98(5):786–806.

    Article  Google Scholar 

  7. Thomas R, Halim S, Gurudas S, Sivaprasad S, Owens D. IDF Diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019;157:107840.

    Article  CAS  Google Scholar 

  8. Tilahun M, Gobena T, Dereje D, Welde M, Yideg G. Prevalence of diabetic retinopathy and its associated factors among diabetic patients at Debre Markos referral hospital, Northwest Ethiopia, 2019: Hospital-Based Cross-Sectional Study. Diabetes Metab Syndr Obes. 2020;13:2179.

    Article  Google Scholar 

  9. Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125(10):1608–22.

    Article  Google Scholar 

  10. Debele GR, Kanfe SG, Weldesenbet AB, Ayana GM, Jifar WW, Raru TB. Incidence of Diabetic Retinopathy and Its Predictors Among Newly Diagnosed Type 1 and Type 2 Diabetic Patients: A Retrospective Follow-up Study at Tertiary Health-care Setting of Ethiopia. Diabetes Metab Syndr Obes. 2021;14:1305.

    Article  Google Scholar 

  11. Pizzarello L, Abiose A, Ffytche T, Duerksen R, Thulasiraj R, Taylor H, et al. VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol. 2004;122(4):615–20.

    Article  Google Scholar 

  12. Kaplan HJ. Anatomy and function of the eye. Immune Response Eye. 2007;92:4–10.

    Article  Google Scholar 

  13. Florkowski C. HbA1c as a diagnostic test for diabetes mellitus–reviewing the evidence. Clin Biochem Rev. 2013;34(2):75.

    Google Scholar 

  14. Sharew G, Ilako DR, Kimani K, Gelaw Y. Prevalence of diabetic retinopathy in Jimma University Hospital, Southwest Ethiopia. Ethiop Med J. 2013;51(2):105–13.

    Google Scholar 

  15. Azeze TK, Sisay MM, Zeleke EG. Incidence of diabetes retinopathy and determinants of time to diabetes retinopathy among diabetes patients at Tikur Anbessa Hospital, Ethiopia: a retrospective follow up study. BMC Res Notes. 2018;11(1):1–6.

    Article  Google Scholar 

  16. Collaborators G, Rawal L. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. 2021.

    Google Scholar 

  17. Tekletsadik EA, Desta AA, Workneh BS. Knowledge, Attitude, and Associated Factors towards Nonpharmacological Pain Management among Nurses Working at Amhara Region Comprehensive Specialized Hospitals, Ethiopia. Crit Care Res Pract. 2021;2021:7374915.

    Google Scholar 

  18. Sivaraj RR, Dodson PM. Diabetic retinopathy: screening to treatment: Oxford University Press; 2020.

  19. Ophthalmologists T. Diabetic Retinopathy Guidelines. Definition of Diabetic Retinopathy. 2012. p. 1.

    Google Scholar 

  20. Giloyan A, Harutyunyan T, Petrosyan V. The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional study. BMC Ophthalmol. 2015;15(1):1–7.

    Article  Google Scholar 

  21. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.

    Article  CAS  Google Scholar 

  22. Cui J, Ren JP, Chen DN, Xin Z, Yuan MX, Xu J, et al. Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study. BMJ Open. 2017;7(8):e015473.

    Article  Google Scholar 

  23. Jonas JB, Nangia V, Khare A, Matin A, Bhojwani K, Kulkarni M, et al. Prevalence and associated factors of diabetic retinopathy in rural central India. Diabetes Care. 2013;36(5):e69-e.

    Article  Google Scholar 

  24. Ponto KA, Koenig J, Peto T, Lamparter J, Raum P, Wild PS, et al. Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS). Diabetologia. 2016;59(9):1913–9.

    Article  Google Scholar 

  25. Rasoulinejad SA, Hajian-Tilaki K, Mehdipour E. Associated factors of diabetic retinopathy in patients that referred to teaching hospitals in Babol. Caspian J Intern Med. 2015;6(4):224.

    Google Scholar 

  26. Lewis AD, Hogg RE, Chandran M, Musonda L, North L, Chakravarthy U, et al. Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study. Eye. 2018;32(7):1201–8.

    Article  Google Scholar 

  27. Hassan M, Akhtar M, Akhtar N. Prevalence of retinopathy and its associated factors in type-2 diabetes mellitus patients visiting hospitals and diabetic clinics in Faisalabad, Pakistan. Pak J Zool. 2010;42(1).

  28. Ababa A. Federal Democratic Republic of Ethiopia central statistical agency population projection of Ethiopia for all regions at Wereda level from 2014–2017. Addis Ababa: Central Statistical Agency; 2014.

    Google Scholar 

  29. Ozawa GY, Bearse MA, Bronson-Castain KW, Harrison WW, Schneck ME, Barez S, et al. Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes. Invest Ophthalmol Vis Sci. 2012;53(6):3040–6.

    Article  Google Scholar 

  30. Akrofi B, Tetteh J, Amissah-Arthur KN, Buxton EN, Yawson A. Utilization of eye health services and diabetic retinopathy: a cross-sectional study among persons living with diabetes visiting a tertiary eye care facility in Ghana. BMC Health Serv Res. 2021;21(1):1–11.

    Article  Google Scholar 

  31. Emoto N, Okajima F, Sugihara H, Goto R. A socioeconomic and behavioral survey of patients with difficult-to-control type 2 diabetes mellitus reveals an association between diabetic retinopathy and educational attainment. Patient Prefer Adherence. 2016;10:2151.

    Article  Google Scholar 

  32. Tao X, Li J, Zhu X, Zhao B, Sun J, Ji L, et al. Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus. Cardiovasc Diabetol. 2016;15(1):1–10.

    Article  Google Scholar 

  33. Cleland CR, Burton MJ, Hall C, Hall A, Courtright P, Makupa WU, et al. Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programme. Tropical Med Int Health. 2016;21(3):417–26.

    Article  Google Scholar 

  34. Fenwick EK, Xie J, Man RE, Sabanayagam C, Lim L, Rees G, et al. Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone. PLoS One. 2017;12(6):e0180252.

    Article  Google Scholar 

  35. Elwali ES, Almobarak AO, Hassan MA, Mahmooud AA, Awadalla H, Ahmed MH. Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study. Int J Ophthalmol. 2017;10(6):948.

    Google Scholar 

  36. Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S, et al. Prevalence and causes of visual impairment in diabetic patients in Tunisia. North Africa Eye. 2014;28(8):986–91.

    CAS  Google Scholar 

  37. Srivastava B, Rema M. Does hypertension play a role in diabetic retinopathy? J Assoc Physicians India. 2005;53:803–8.

    CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge University of Gondar for its voluntariness to conduct this research project, University of Gondar Specialized Comprehensive Hospitals found in the northwest Ethiopia, and data collectors.

Funding

No funding

Author information

Authors and Affiliations

Authors

Contributions

AFZ: conceptualized the study and was involved in design, analysis, interpretation, report and manuscript writing. YZT: involved in analysis, interpretation, report, and manuscript writing. CKM: involved in analysis, interpretation, report, and manuscript writing and supervision. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Alebachew Ferede Zegeye.

Ethics declarations

Ethics approval and consent to participate

Ethical clearance was obtained from the School of Nursing research ethical review commute on the behalf of University of Gondar institutional review board. Written permission letters were obtained from Hospital managers. Participants were informed about the purpose of the study and verbal informed consent (for illiterate) and written informed consent (for literate) was obtained from them and the informed consent was approved by Ethical Review Committee (ERC) of the University of Gondar College of Medicine School of nursing (S/N/164/7/2014). Confidentiality was maintained by omitting direct personal identifiers on the questionnaire, by using code numbers, storing data locked with a password, and not misuse or disclose their information. Participants were also informed that participation was voluntary and they have the right to withdraw from the study participation at any stage if they are not comfortable with the investigation. The issue of privacy and confidentiality was strictly maintained.

All methods were performed in accordance with the relevant guidelines and regulations or in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declared that there is no competing interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zegeye, A.F., Temachu, Y.Z. & Mekonnen, C.K. Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021. BMC Ophthalmol 23, 9 (2023). https://doi.org/10.1186/s12886-022-02746-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-022-02746-8

Keywords